Highland Capital Management Fund Advisors, L.P. Horizon Therapeutics Public LTD CO Transaction History

Highland Capital Management Fund Advisors, L.P.

$846 Million
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $6.1 Million - $7.12 Million	-63,351 Reduced 9.82%	581,947 $59.9 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $14.3 Million - $15.1 Million	133,000 Added 25.96%	645,298 $70.4 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $32 Million - $58.3 Million	512,298 New	512,298 $58.3 Million
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $535,804 - $680,822	-6,200 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $611,072 - $743,442	6,200 New	6,200 $668,000

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management Fund Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management Fund Advisors, L.P. with notifications on news.

Account